Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Finally an answer of GA!!!next week we will be trading again
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(68)
•••
Post by Banderas1209on Sep 09, 2020 1:42am
340 Views
Post# 31525192

Finally an answer of GA!!!next week we will be trading again

Finally an answer of GA!!!next week we will be trading again Dear Friend; We have been working hard for these last “COVID” months to advance the Company and expect to close our current financing and be trading again in the next week. I will be doing a seminar tomorrow on our unique ability to analyze the right ventricle of the heart with renown investor and doctor, Mark Swain (AKA Dr. KSS) and his large network of biotech investors. Tune in and hear how we have advanced the VMS+3.0 and how relevant it is to COVID-induced heart disease. You are invited to a Zoom webinar. When: Sep 9, 2020 12:00 PM Eastern Time (US and Canada) Topic: Ventripoint and the Unknown Known: Meet the Right Ventricle Please click the link below to join the webinar: https://us02web.zoom.us/j/82775007679 Or iPhone one-tap : US: +16465588656,,82775007679# or +13017158592,,82775007679# Or Telephone: Dial(for higher quality, dial a number based on your current location): US: +1 646 558 8656 or +1 301 715 8592 or +1 312 626 6799
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities